90例癌症患者与180例匹配对照在生育力保存卵巢刺激后卵泡生长及卵母细胞队列的前瞻性评估
这项前瞻性非干预研究比较了90例癌症患者与180例时间及年龄匹配的健康对照在控制性卵巢刺激后的卵泡生长模式和卵母细胞队列,主要结局为MII卵母细胞总数及MII/总卵母细胞率。癌症组基础抗苗勒管激素水平(P < 0.05)和窦卵泡计数(P < 0.0001)显著更低,重组FSH总剂量显著更高(P < 0.0001),获卵MII卵母细胞数(6.2 ± 4.7 vs 8.8 ± 4.2;P < 0.0001)及MII/总卵母细胞率(56% vs 78%,P < 0.0001)显著更低。
要点
- 癌症患者基础AMH和窦卵泡计数显著低于匹配健康对照。
- 癌症组重组FSH总剂量显著高于对照组,刺激时长及成熟卵泡数无差异。
- 癌症组获卵MII卵母细胞数及MII/总卵母细胞率显著低于对照。
核心结论
- 癌症患者在控制性刺激后获卵MII卵母细胞数更少且成熟率更低,可玻璃化冷冻的MII卵母细胞更少。
研究设计与样本
- 前瞻性非干预研究,90例开始化疗前招募的癌症患者与180例时间及年龄匹配的健康对照(接受卵胞浆内单精子注射)进行比较。
主要发现
- 癌症组基础抗苗勒管激素水平显著低于对照(P < 0.05),窦卵泡计数显著低于对照(P < 0.0001)。
- 癌症组重组FSH总剂量显著高于对照(P < 0.0001)。
- 刺激时长、排卵诱导日成熟卵泡均数及取卵总数在组间无差异。
- 癌症组获卵MII卵母细胞数为6.2 ± 4.7,对照组为8.8 ± 4.2,癌症组显著低于对照(P < 0.0001)。
- 癌症组MII卵母细胞/总卵母细胞比率为56%,对照组为78%,癌症组显著低于对照(P < 0.0001)。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A lower number of metaphase II oocytes eligible for vitrification after controlled stimulation in cancer patients has recently been reported, suggesting that cancer may impair the dynamics and quality of follicular growth. In this prospective, non-interventional study, the pattern of follicular growth and oocyte cohort after ovarian stimulation in cancer patients was analysed. Ninety cancer patients, recruited before starting chemotherapy, were compared with 180 time- and age-matched healthy controls undergoing intracytoplasmic sperm injection. Primary outcome was total number of metaphase II oocytes and metaphase II /total oocytes rate. Basal anti-Müllerian hormone levels (P < 0.05) and antral follicle count (P < 0.0001) were significantly lower in cancer patients. Recombinant FSH total dose was significantly higher in the cancer group (P < 0.0001). No differences were found in duration of stimulation, mean number of mature follicles on day of ovulation induction and total oocyte number after retrieval; the number of metaphase II oocytes retrieved (6.2 ± 4.7 versus 8.8 ± 4.2; P < 0.0001) and number of metaphase II oocytes-total oocytes ratio were significantly lower in cancer patients (56% versus 78%, P < 0.0001). Fewer metaphase II oocytes were eligible for vitrification and lower maturation rate in the cancer group.
引用
- Decanter C, Robin G, Mailliez A, et al. Prospective assessment of follicular growth and the oocyte cohort after ovarian stimulation for fertility preservation in 90 cancer patients versus 180 matched controls. Reprod Biomed Online. 2018. PMID: 29506861. doi:10.1016/j.rbmo.2018.01.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。